Shiping Jiao

1.4k total citations · 1 hit paper
9 papers, 1.1k citations indexed

About

Shiping Jiao is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Shiping Jiao has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Shiping Jiao's work include CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Single-cell and spatial transcriptomics (2 papers). Shiping Jiao is often cited by papers focused on CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Single-cell and spatial transcriptomics (2 papers). Shiping Jiao collaborates with scholars based in China, United States and Taiwan. Shiping Jiao's co-authors include Heng‐Huan Lee, Sam S. Chang, Mien‐Chie Hung, Mei‐Kuang Chen, Yi Du, Gabriel N. Hortobágyi, Chia‐Wei Li, Chao‐Kai Chou, Wen-Hsuan Yu and Hirohito Yamaguchi and has published in prestigious journals such as Cell, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Shiping Jiao

9 papers receiving 1.1k citations

Hit Papers

PARP Inhibitor Upregulates PD-L1 Expression and Enhances ... 2017 2026 2020 2023 2017 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiping Jiao China 6 917 401 391 229 127 9 1.1k
Mei‐Kuang Chen United States 12 912 1.0× 348 0.9× 527 1.3× 191 0.8× 131 1.0× 24 1.2k
Alexandra S. Zimmer United States 13 815 0.9× 192 0.5× 365 0.9× 344 1.5× 110 0.9× 24 1.1k
Wen-Hsuan Yu Taiwan 6 1.0k 1.1× 283 0.7× 801 2.0× 191 0.8× 446 3.5× 8 1.5k
Lizhou Jia China 19 433 0.5× 224 0.6× 468 1.2× 123 0.5× 265 2.1× 45 968
Stephen P. Santoro United States 6 815 0.9× 603 1.5× 352 0.9× 113 0.5× 160 1.3× 9 1.1k
Takaaki Yasuhara Japan 12 663 0.7× 311 0.8× 713 1.8× 171 0.7× 128 1.0× 22 1.2k
Aleksandra Ogurtsova United States 10 594 0.6× 301 0.8× 211 0.5× 77 0.3× 59 0.5× 17 776
Ryota Sekine Japan 5 524 0.6× 225 0.6× 369 0.9× 134 0.6× 85 0.7× 6 743
Nicholas G. Minutolo United States 7 512 0.6× 559 1.4× 321 0.8× 96 0.4× 86 0.7× 9 955
Yuan Mao China 20 445 0.5× 266 0.7× 497 1.3× 123 0.5× 152 1.2× 58 946

Countries citing papers authored by Shiping Jiao

Since Specialization
Citations

This map shows the geographic impact of Shiping Jiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiping Jiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiping Jiao more than expected).

Fields of papers citing papers by Shiping Jiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiping Jiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiping Jiao. The network helps show where Shiping Jiao may publish in the future.

Co-authorship network of co-authors of Shiping Jiao

This figure shows the co-authorship network connecting the top 25 collaborators of Shiping Jiao. A scholar is included among the top collaborators of Shiping Jiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiping Jiao. Shiping Jiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Wang, Shuhang, Peiwen Ma, Jingchao Liu, et al.. (2025). Phase I trial of personalized AI-identified TCR-transduced T cell therapy in advanced solid tumors.. Journal of Clinical Oncology. 43(16_suppl). 2535–2535. 1 indexed citations
2.
Li, Yanchuan, Huamei Li, Cheng Peng, et al.. (2024). Unraveling the spatial organization and development of human thymocytes through integration of spatial transcriptomics and single-cell multi-omics profiling. Nature Communications. 15(1). 7784–7784. 7 indexed citations
3.
Zhou, Huan, Huijuan Zheng, Yucai Peng, et al.. (2024). Efficacy, safety, and immunogenicity of SARS-CoV-2 mRNA vaccine (Omicron BA.5) LVRNA012: a randomized, double-blind, placebo-controlled phase 3 trial. Frontiers in Immunology. 15. 1407826–1407826. 2 indexed citations
4.
Jiao, Shiping, Qing Xiong, Meisi Yan, et al.. (2022). Intratumor expanded T cell clones can be non-sentinel lymph node derived in breast cancer revealed by single-cell immune profiling. Journal for ImmunoTherapy of Cancer. 10(1). e003325–e003325. 13 indexed citations
5.
Yang, Fan, Tianyu Zeng, Chunxiao Sun, et al.. (2021). Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysis. Journal of Experimental & Clinical Cancer Research. 40(1). 142–142. 31 indexed citations
6.
Jiao, Shiping, Sumit K. Subudhi, Ana M. Aparicio, et al.. (2019). Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy. Cell. 179(5). 1177–1190.e13. 277 indexed citations
7.
Jiao, Shiping, Weiya Xia, Hirohito Yamaguchi, et al.. (2017). PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression. Clinical Cancer Research. 23(14). 3711–3720. 768 indexed citations breakdown →
8.
Jiao, Shiping, Wenjie Liu, Minqing Wu, et al.. (2015). Nrdp1 expression to predict clinical outcome and efficacy of adjuvant anthracyclines-based chemotherapy in breast cancer: A retrospective study. Cancer Biomarkers. 15(2). 115–123. 5 indexed citations
9.
Jiao, Shiping, Minqing Wu, Feng Ye, et al.. (2014). BikDDA, a Mutant of Bik with Longer Half-Life Expression Protein, Can Be a Novel Therapeutic Gene for Triple-Negative Breast Cancer. PLoS ONE. 9(3). e92172–e92172. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026